Alaunos Therapeutics | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Adcock Ingram Holdings ZAR 1.61B 802K 2024-06
Alaunos Therapeutics -1127000 1.11M 2024-09
Amgen USD 5.97B 781M 2024-12
AstraZeneca USD 12.17B 1.06B 2024-12
Baxter International USD 1.02B 19M 2024-12
Biogen USD 1.87B 44.1M 2024-12
Bioline Rx USD 4.12M 375K 2024-09
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Celltrion KRW 463.41B 95.59B 2024-09
Corcept Therapeutics USD 178.93M 745K 2024-12
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Ecofibre AUD 2.08M 4.33M 2024-06
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.56B 57M 2024-12
Incyte USD 1.1B 38.34M 2024-12
Ionis Pharmaceuticals USD 222.75M 90M 2024-12
J&J USD 14.6B 816M 2025-03
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 13.36M 2.36M 2024-06
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Pfizer USD 12.11B 718M 2024-12
Pharma Mar EUR 47.05M 3.4M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Qiagen NV USD 349.8M 19.17M 2024-12
Regeneron Pharmaceuticals USD 3.22B 1.88B 2024-12
Roche Holding CHF 11.69B 48M 2024-12
Sartorius EUR 431M 36.4M 2025-03
Sino Biopharmaceutical CNY 10.5B 3.99B 2024-12
TG Therapeutics USD 92.79M 18.25M 2024-12
Tilray USD 61.22M 1.51M 2024-11
Zz Pientze Pharmaceu 1.29B 268M 2024-09



Alaunos Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.